• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Marex Group plc

    6/23/25 4:08:02 PM ET
    $MRX
    Investment Bankers/Brokers/Service
    Finance
    Get the next $MRX alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001379623
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    Marex Group plc
    SEC File Number
    001-42020
    Address of Issuer
    155 Bishopsgate London
    UNITED KINGDOM EC2M 3TQ
    UNITED KINGDOM
    na
    Phone
    442076556000
    Name of Person for Whose Account the Securities are To Be Sold
    Ian Lowitt
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    CEO

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common Stock
    J.P. Morgan Securities LLC
    390 Madison Avenue
    6th Floor
    New York � NY � 10017
    21000082194007123170606/23/2025
    Nasdaq


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common05/24/2024CompensationIssuerCheckbox not checked2463105/24/2024NA
    Common05/24/2024CompensationIssuerCheckbox not checked461205/24/2024NA
    Common05/16/2025CompensationIssuerCheckbox not checked7563505/16/2025NA
    Common03/10/2025CompensationIssuerCheckbox not checked461203/10/2025NA
    Common03/10/2025CompensationIssuerCheckbox not checked10051003/10/2025NA

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    The sales of shares set forth herein are made in connection with a selling plan entered into on 14 March 2025 that is intended to comply with Rule 10b5-1
    Date of Notice
    06/23/2025
    Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
    03/14/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Ian Lowitt

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $MRX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MRX

    DatePrice TargetRatingAnalyst
    3/10/2025$33.00 → $36.00Buy → Hold
    HSBC Securities
    11/21/2024$33.00Buy
    HSBC Securities
    11/6/2024$34.00Buy
    Citigroup
    5/20/2024$33.00Buy
    Goldman
    5/20/2024$25.00Overweight
    Barclays
    5/20/2024$27.00Overweight
    Piper Sandler
    5/20/2024$27.00Buy
    UBS
    5/20/2024$24.00Buy
    Jefferies
    More analyst ratings

    $MRX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Marex Agrees to Acquire Agrinvest Commodities

      LONDON, June 05, 2025 (GLOBE NEWSWIRE) -- Marex Group plc ((‘Marex' or the ‘Group', NASDAQ:MRX), the diversified global financial services platform, today announces that it has agreed to acquire Agrinvest Commodities, a Brazilian agricultural commodities business. This acquisition will expand Marex's operations in the Americas and add new capabilities and clients to diversify earnings. Agrinvest acts as an agent connecting buyers and sellers in physical agricultural markets including corn and soybeans. It also provides its clients with consulting support to understand their hedging options and commercial strategies within these agricultural markets. Acquiring Agrinvest gives Marex physic

      6/5/25 7:00:06 AM ET
      $MRX
      Investment Bankers/Brokers/Service
      Finance
    • Marex Group plc to Participate in Upcoming Piper Sandler Global Exchange & Trading Conference

      NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (NASDAQ:MRX) ("Marex"), the diversified global financial services platform, announces that it will be participating in a fireside chat at Piper Sandler's Global Exchange & Trading Conference. The presentation will be given by Ian Lowitt, Group Chief Executive Officer and will take place on Thursday, June 5th at 8:00 a.m. ET. The event will be available via webcast and can be accessed here: https://www.wsw.com/webcast/pipersandler44/marx/2943128 About Marex:Marex Group plc (NASDAQ:MRX) is a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across en

      6/2/25 7:00:00 AM ET
      $MRX
      Investment Bankers/Brokers/Service
      Finance
    • Marex announces departure of Roger Nagioff from the Group Board

      LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Marex Group Plc (NASDAQ:MRX), the diversified global financial services platform, announces today that Roger Nagioff has stepped down from the Group Board. Roger represented private equity investors on the Board. Before Marex's initial public offering (IPO) on Nasdaq in April 2024, private equity shareholders including JRJ Group held around 96% of Marex stock. Following the IPO and two successful secondary follow-on offerings, private equity owners now hold around 30% of Marex stock. Roger was a member of the Board for 15 years and is a founding partner of JRJ Group. A process is underway to find a new member of the Group Board. He was a membe

      5/15/25 7:00:35 AM ET
      $MRX
      Investment Bankers/Brokers/Service
      Finance